Literature DB >> 16705708

Effect of oral diacerein (DAR) in an experimental hip chondrolysis model.

Humberto Ken Kitadai1, Hélio Kyoshi Takahashi, Anita Hilda Straus, José Fernando Ibanez, Ronald Lucas, Fábio Takashi Kitadai, Carlo Milani.   

Abstract

We aimed to reproduce the articular cartilage structural changes in a joint exposed to a metallic implant as in the adolescent pinned hip with persistent joint penetration and secondly, to test the effect of an interleukin inhibitor, diacerein (DAR) in the ensuing articular cartilage lesion. Twenty immature beagles were submitted to a surgical K-wire implantation in the hip with the material left in the joint space for 6 months. Twelve animals were sacrificed for histological and biochemical tests. Eight animals were sacrificed at 10 months (half of them treated with DAR) and analyzed by scanning electron microscopy (SEM) and biochemistry of the articular cartilage. Preoperative and monthly C3 and C4 complement and immunoglobulins serum levels were determined. The histological and the electrophoretic profile changes were significative at 6 months. At 10 months the migration profile (CaCl2) recovered to normal levels in the operated hip and the SEM scores for the acetabulum were similar to the non operated control hip after treatment. The serum level of IgA was elevated at the 4th and 6th month postoperatively. The persistence of a metallic implant resulted in degenerative changes parallel to that described for hip chondrolysis as a complication of in-situ pinning; and the cartilage lesion improved with DAR treatment. (c) 2006 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16705708     DOI: 10.1002/jor.20180

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  3 in total

Review 1.  Pharmaceutical therapeutics for articular regeneration and restoration: state-of-the-art technology for screening small molecular drugs.

Authors:  Yishan Chen; Heng Sun; Xudong Yao; Yeke Yu; Tian Tian; Weiyang Xu; Yujie Zhou; Hongwei Ouyang
Journal:  Cell Mol Life Sci       Date:  2021-11-16       Impact factor: 9.261

2.  Ion-pair compounds of diacerein for enhancing skin permeability in vitro: the compatibility-permeability relationship of counter ion and diacerein.

Authors:  Yan Liang; Manzhen Duan; Wei Yi; Teng Zhang; Yonggang Wang; Zhiming Wu; Huaibo Tang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 3.  Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO.

Authors:  Karel Pavelka; Olivier Bruyère; Cyrus Cooper; John A Kanis; Burkhard F Leeb; Emmanuel Maheu; Johanne Martel-Pelletier; Jordi Monfort; Jean-Pierre Pelletier; René Rizzoli; Jean-Yves Reginster
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.